{"id":2136,"date":"2026-10-09T21:15:47","date_gmt":"2026-10-09T13:15:47","guid":{"rendered":"http:\/\/www.puriactives.com\/en\/?p=2136"},"modified":"2026-10-09T21:15:47","modified_gmt":"2026-10-09T13:15:47","slug":"puriactives-supra-series","status":"publish","type":"post","link":"http:\/\/www.puriactives.com\/en\/?p=2136","title":{"rendered":"PuriActives\u00ae Supra Series"},"content":{"rendered":"

01 \u00b7 PuriActives\u00ae Supra Series<\/h2>\n

From difficult-to-use actives to formulation-ready performance.<\/p>\n

PuriPharm Co., Ltd. Cosmetic Active Ingredients. Technical Presentation.<\/p>\n

\"\"<\/p>\n

02 \u00b7 Why Supramolecular Technology: Active Value and Formulation Challenges<\/h2>\n

High-value ingredients with biological activity or efficacy potential can still face 11 common challenges in real cosmetic formulations.<\/p>\n

Solubility and dispersion: insufficient water solubility, difficult dispersion, crystallization or precipitation, and uneven distribution.<\/p>\n

Stability: limited oxidative stability, limited light stability, and pH sensitivity.<\/p>\n

Compatibility and application: limited formulation compatibility, dependence on organic solvents, difficult development, and incomplete translation of molecular activity into finished-product performance.<\/p>\n

Core conclusion: scientific value becomes product value when an active can be incorporated successfully, remain stable, distribute uniformly, and perform effectively.<\/p>\n

03 \u00b7 Supramolecular Chemistry: Recognition, Organization, and Cooperation<\/h2>\n

Conventional chemistry examines how atoms form molecules through covalent bonds. Supramolecular chemistry examines how molecules recognize, bind, arrange, and cooperate through reversible noncovalent interactions to form higher-order organized systems.<\/p>\n

Definition: the science of ordered molecular assemblies formed through noncovalent interactions.<\/p>\n

Key interactions: hydrogen bonding, electrostatic and hydrophobic interactions, van der Waals forces, \u03c0\u2013\u03c0 interactions, host\u2013guest interactions, molecular recognition, and metal-ion coordination.<\/p>\n

Individual molecules organize into supramolecular assemblies through reversible noncovalent interactions.<\/p>\n

Sources: Lehn J.-M. Supramolecular Chemistry. Science 1993, 260, 1762\u20131763. DOI: 10.1126\/science.8511582; Supramolecular Chemistry\u2014Scope and Perspectives (Nobel Lecture). Angew. Chem. Int. Ed. 1988, 27, 89\u2013112.<\/p>\n

\"\"<\/p>\n

04 \u00b7 Understanding the System: Optimizing the Molecular Environment<\/h2>\n

Conventional active performance depends on the aqueous and oil phases, pH, salts, temperature, and other ingredients. Functional components in a supramolecular system create a cooperative molecular environment around the active.<\/p>\n

The presentation compares this to a molecular team supporting an active facing formulation challenges.<\/p>\n

Conventional pathway: an isolated active encounters an unfavorable environment and solubility, stability, and compatibility problems.<\/p>\n

Supramolecular pathway: the active and functional supporting components form an organized system through noncovalent interactions, creating an environment better suited to formulation.<\/p>\n

\"\"<\/p>\n

05 \u00b7 System Formation: From Separate Components to a Dynamic Network<\/h2>\n

An active, functional supporting components, and an aqueous phase or specific formulation environment organize into a dynamic supramolecular network through reversible noncovalent interactions.<\/p>\n

These include hydrogen bonding, electrostatic interactions, hydrophobic association, molecular recognition, and coordination. The reversible, dynamic, cooperative network creates a functional molecular environment.<\/p>\n

A supramolecular system does not necessarily create a new covalent chemical substance. Its function arises from component organization, interactions, and cooperative behavior.<\/p>\n

\"\"<\/p>\n

06 \u00b7 Conventional Actives and Supramolecular Systems<\/h2>\n

Conventional actives primarily rely on individual molecules. Performance depends strongly on solvent conditions, with potential solubility and dispersion problems. Stability and compatibility require separate solutions, while actives and supporting systems remain relatively independent.<\/p>\n

Supramolecular systems combine functional components and tailor the molecular environment. They can support compatibility and uniform distribution, reduce some application barriers, and provide complementary functions, with emphasis on finished-product performance.<\/p>\n

Purposeful organization offers the possibility of synergistic value greater than the sum of its parts. This describes a platform design objective rather than verified synergy for every product.<\/p>\n

07 \u00b7 From Formulation Challenges to Solutions<\/h2>\n

The table maps formulation challenges to molecular strategies and practical value for formulators. Development starts from a formulation problem and uses molecular strategies to create actionable formulation value.<\/p>\n\n\n\n\n\n\n\n\n\n
Formulation challenge<\/th>\nSupramolecular strategy<\/th>\nFormulation value<\/th>\n<\/tr>\n
Insufficient water solubility<\/td>\nCreate a hydrophilic molecular environment<\/td>\nEasier incorporation into water-based systems<\/td>\n<\/tr>\n
Crystallization or precipitation<\/td>\nIntermolecular interactions and organized assembly<\/td>\nImproved dispersion and storage performance<\/td>\n<\/tr>\n
Insufficient stability<\/td>\nCreate a supportive microenvironment<\/td>\nImproved formulation robustness<\/td>\n<\/tr>\n
Limited system compatibility<\/td>\nA cooperative multicomponent molecular system<\/td>\nGreater formulation flexibility<\/td>\n<\/tr>\n
Uneven distribution<\/td>\nImprove molecular-level dispersion<\/td>\nMore uniform active distribution<\/td>\n<\/tr>\n
Limited active functionality<\/td>\nCombine with functional supporting components<\/td>\nMultidimensional formulation value<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

08 \u00b7 Supra Series: A Platform for Real Formulations<\/h2>\n

PuriActives\u00ae Supra Series comprises multifunctional supramolecular active systems. Each combines a high-value cosmetic active with designed functional supporting components according to its molecular properties. Noncovalent interactions create a cooperative environment intended to improve ease of use, compatibility, and overall functional value.<\/p>\n

The platform can expand to different actives.<\/p>\n

Three layers: the core active, a supramolecular support system, and a formulation-ready functional system.<\/p>\n

\"\"<\/p>\n

09 \u00b7 Development Purpose: Bridging Scientific Potential and Commercial Formulations<\/h2>\n

A molecule with scientific potential is not automatically a formulation-ready commercial cosmetic ingredient.<\/p>\n

01 Improve the practical value of high-value actives.<\/p>\n

02 Make difficult actives easier to formulate.<\/p>\n

03 Improve use in water-based systems.<\/p>\n

04 Support stability and uniform distribution.<\/p>\n

05 Reduce development barriers.<\/p>\n

06 Create multifunctional cooperative systems through supporting components.<\/p>\n

07 Translate scientific potential into commercially feasible ingredients.<\/p>\n

08 Bring active concepts closer to finished-product development.<\/p>\n

10 \u00b7 Core Objective: Connecting Molecular Potential and Real Performance<\/h2>\n

To make high-value active ingredients easier to use and more effective in real cosmetic formulations through supramolecular organization.<\/p>\n

The pathway connects molecular potential, supramolecular organization, formulation performance, and perceptible product value.<\/p>\n

\"\"<\/p>\n

11 \u00b7 Four Development Principles<\/h2>\n

01 Formulation readiness: turn difficult actives into convenient ingredient systems.<\/p>\n

02 Molecular compatibility: create a suitable physicochemical environment.<\/p>\n

03 Synergistic functionality: combine complementary functions of the core active and supporting components.<\/p>\n

04 Real formulation performance: consider experimental molecular activity alongside the actual state of use in finished cosmetics.<\/p>\n

Supra applies supramolecular science to real formulation needs.<\/p>\n

12 \u00b7 Typical Architecture of a Supra System<\/h2>\n

A system may include a core active, metal ions or mineral-derived functional components, polysaccharide or oligosaccharide supporting components, and hydrophilic and hydrophobic regions.<\/p>\n

Hydrogen-bond networks, electrostatic interactions, and coordination contribute to a dynamic cooperative supramolecular network. Dashed lines illustrate hydrogen bonding and dynamic cooperation.<\/p>\n

The diagram presents the platform\u2019s general design logic. Specific components and organization depend on the core active\u2019s physicochemical properties and intended use.<\/p>\n

\"\"<\/p>\n

13 \u00b7 Representative Products<\/h2>\n

S1 PuriActives\u00ae SupraFerulix™: a supramolecular ferulic acid system. Ferulic acid offers antioxidant and photoaging-care potential but faces solubility, stability, and compatibility challenges in aqueous formulations.<\/p>\n

S2 PuriActives\u00ae SupraSalix: a supramolecular salicylic acid system. Salicylic acid supports pore cleansing, exfoliation, and oily\/acne-prone skin care, with limitations in water solubility and pH compatibility.<\/p>\n

S3 PuriActives\u00ae SupraHDA™: a supramolecular 10-HDA system. This characteristic royal-jelly-related functional molecule has skin and scalp care potential but presents practical formulation challenges.<\/p>\n

S4 PuriActives\u00ae SupraCaffix™: a supramolecular caffeic acid system. Caffeic acid offers polyphenol antioxidant value, with aqueous solubility, oxidative stability, and compatibility requiring optimization.<\/p>\n

Sources: Srinivasan et al. 2007; Saija et al. 2000; Arif 2015; Zhang et al. 2022; Sugiyama et al. 2012; Yang et al. 2018. Original bibliographic details appear in the final section.<\/p>\n

14 \u00b7 Supramolecular Organization and Conventional Delivery<\/h2>\n

Supramolecular technology is defined by purposeful molecular organization and functional cooperation through reversible noncovalent interactions. Its definition does not depend on nanoscale size or physical encapsulation.<\/p>\n

It can combine with liposomes, nanodelivery, and other technologies, with a distinct design rationale. The table summarizes the main features.<\/p>\n\n\n\n\n\n\n\n\n
Technology<\/th>\nMain features<\/th>\n<\/tr>\n
Solubilization<\/td>\nPrimarily improves dissolution or dispersion in a solvent.<\/td>\n<\/tr>\n
Microcapsules \/ encapsulation<\/td>\nPrimarily encloses actives within physical wall materials.<\/td>\n<\/tr>\n
Liposomes<\/td>\nPrimarily carries actives in lipid bilayers or vesicles.<\/td>\n<\/tr>\n
Nanodelivery<\/td>\nTypically focuses on particle size, surface area, dispersion, and delivery performance.<\/td>\n<\/tr>\n
Supramolecular technology<\/td>\nOrganizes molecules into cooperative systems through reversible noncovalent interactions.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

15 \u00b7 Value for Formulators: Practical Molecular Science<\/h2>\n

Ease of use: easier incorporation, reduced reliance on strong solvents, and support for water-based development.<\/p>\n

Formulation performance: supports uniform distribution, design flexibility, and formats including serums, gels, and lotions.<\/p>\n

Development value: opportunities for multifunctional concepts, simpler development steps, new scalp-serum and cleansing\/conditioning applications, and translation of high-value molecules into commercial products.<\/p>\n

Advanced molecular science made practical for formulators. The image illustrates development across serum, gel, and lotion formats.<\/p>\n

\"\"<\/p>\n

16 \u00b7 Skin, Hair, and Scalp Care Directions<\/h2>\n

Skin care: antioxidant care, aging and photoaging care, skin brightening, oily\/acne-prone skin care, exfoliation, soothing, barrier support, sensitive-skin formulations, protection from external stressors, serums, and functional lotions.<\/p>\n

Hair and scalp care: scalp sebum management, soothing, antioxidant care, microenvironment management, pollution protection, scalp serums, functional shampoos and conditioners, and comprehensive hair\/scalp care.<\/p>\n

Specific directions for each Supra product should follow its core active and actual test data.<\/p>\n

17 \u00b7 Key Questions, Answered<\/h2>\n

Q1 What is supramolecular technology? It purposefully organizes molecules into cooperative functional systems through noncovalent interactions such as hydrogen bonding, electrostatic and hydrophobic interactions, and molecular recognition, creating a suitable environment for actives.<\/p>\n

Q2 Why develop Supra Series? To address limitations in solubility, stability, dispersion, compatibility, and practical use, bridging molecular potential and real formulation performance.<\/p>\n

18 \u00b7 Molecular Organization. Formulation Freedom. Active Performance.<\/h2>\n

Building the molecular environment where actives perform better.<\/p>\n

PuriPharm Co., Ltd.<\/p>\n

Selected references below retain the bibliographic information supplied in the presentation.<\/p>\n

Lehn J.-M. Science 1993, 260, 1762\u20131763. DOI: 10.1126\/science.8511582<\/p>\n

Lehn J.-M. Angew. Chem. Int. Ed. 1988, 27, 89\u2013112. DOI: 10.1002\/anie.198800891<\/p>\n

Cram D. J. Angew. Chem. Int. Ed. 1988, 27, 1009\u20131020.<\/p>\n

Pedersen C. J. Angew. Chem. Int. Ed. 1988, 27, 1021\u20131027.<\/p>\n

Lehn J.-M. Proc. Natl. Acad. Sci. USA 2002, 99, 4763\u20134768.<\/p>\n

Lehn J.-M. Chem. Soc. Rev. 2007, 36, 151\u2013160. DOI: 10.1039\/b616752g<\/p>\n

Aida T., Meijer E. W., Stupp S. I. Science 2012, 335, 813\u2013817.<\/p>\n

Webber M. J., Langer R. Chem. Soc. Rev. 2017, 46, 6600\u20136620.<\/p>\n

Srinivasan M. et al. J. Clin. Biochem. Nutr. 2007, 40, 92\u2013100.<\/p>\n

Saija A. et al. Int. J. Pharm. 2000, 199, 39\u201347.<\/p>\n

Arif T. Clin. Cosmet. Investig. Dermatol. 2015, 8, 455\u2013461. DOI: 10.2147\/CCID.S84765<\/p>\n

Zhang L. et al. J. Cosmet. Dermatol. 2022, 21, 3398\u20133405.<\/p>\n

Sugiyama T. et al. Endocr. Metab. Immune Disord. Drug Targets 2012.<\/p>\n

Yang Y.-C. et al. BMC Complement. Altern. Med. 2018, 18.<\/p>\n","protected":false},"excerpt":{"rendered":"

01 \u00b7 PuriActives\u00ae Supra Series From difficult-to-use ac […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[25],"tags":[],"_links":{"self":[{"href":"http:\/\/www.puriactives.com\/en\/index.php?rest_route=\/wp\/v2\/posts\/2136"}],"collection":[{"href":"http:\/\/www.puriactives.com\/en\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.puriactives.com\/en\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.puriactives.com\/en\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"http:\/\/www.puriactives.com\/en\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2136"}],"version-history":[{"count":1,"href":"http:\/\/www.puriactives.com\/en\/index.php?rest_route=\/wp\/v2\/posts\/2136\/revisions"}],"predecessor-version":[{"id":2153,"href":"http:\/\/www.puriactives.com\/en\/index.php?rest_route=\/wp\/v2\/posts\/2136\/revisions\/2153"}],"wp:attachment":[{"href":"http:\/\/www.puriactives.com\/en\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2136"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.puriactives.com\/en\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=2136"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.puriactives.com\/en\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=2136"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}